Compounds > amoxicillin
Page last updated: 2024-08-23

amoxicillin and Communicable Diseases, Emerging

amoxicillin has been researched along with Communicable Diseases, Emerging in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR1
Kumar, P; Mitra, N1
Beovic, B; Blanche, S; Brousse, N; Galmiche, L; Güngör, T; Holland, SM; Kayal, S; Lopatin, U; Mahlaoui, N; Reichenbach, J; Seger, RA; Siler, U; Zbinden, R1
Agyeman, P; Berlinger, L; Grunt, S; Liniger, B; Ritz, N; Zimmermann, P1

Other Studies

4 other study(ies) available for amoxicillin and Communicable Diseases, Emerging

ArticleYear
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States

2010
Lactococcus garvieae: An Emerging Pathogen.
    Indian pediatrics, 2015, Volume: 52, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Communicable Diseases, Emerging; Female; Gram-Positive Bacterial Infections; Humans; Lactococcus

2015
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Dec-01, Volume: 49, Issue:11

    Topics: Actinomyces; Actinomycosis; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bone Marrow Transplantation; Ceftriaxone; Child; Clindamycin; Communicable Diseases, Emerging; DNA, Ribosomal; Female; Granulomatous Disease, Chronic; Humans; Male; Meropenem; Penicillin G; Penicillin V; Polymerase Chain Reaction; Sulfamethoxazole; Thienamycins; Trimethoprim; Young Adult

2009
Actinobaculum schaalii an emerging pediatric pathogen?
    BMC infectious diseases, 2012, Aug-28, Volume: 12

    Topics: Actinomycetaceae; Amoxicillin; Anti-Bacterial Agents; Communicable Diseases, Emerging; DNA, Bacterial; DNA, Ribosomal; Gram-Positive Bacterial Infections; Humans; Infant; Male; Meningomyelocele; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Tract Infections; Urine; White People

2012